This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Johns Hopkins University. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Antonella Mangraviti: Innovator in Brain Tumor Treatment
Introduction
Antonella Mangraviti is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of medical science, particularly in the treatment of brain tumors. With a total of 2 patents, her work focuses on innovative delivery systems for therapeutic agents.
Latest Patents
One of her latest patents is titled "Selective dendrimer delivery to brain tumors." This invention involves a composition comprising poly(amidoamine) (PAMAM) hydroxyl-terminated dendrimers that are covalently linked to therapeutic, prophylactic, or diagnostic agents. These dendrimers are designed to treat or alleviate symptoms of brain tumors by providing selective delivery through the blood-brain barrier. The G6 dendrimers have shown unexpectedly high uptake into the brain, allowing for the simultaneous delivery of different classes of compounds.
Another significant patent is related to "Local delivery forms of acriflavine for treating tumors." This invention presents local delivery formulations of the antineoplastic and microbicide agent acriflavine. These formulations have been shown to significantly increase the median survival of subjects with proliferative disease compared to systemic administrations. The local delivery method enhances efficacy while minimizing toxicity.
Career Highlights
Antonella Mangraviti is affiliated with The Johns Hopkins University, where she continues her research and development in innovative medical treatments. Her work has garnered attention for its potential to improve patient outcomes in oncology.
Collaborations
She collaborates with notable colleagues, including Betty M. Tyler and Kannan Rangaramanujam, contributing to a dynamic research environment focused on advancing medical science.
Conclusion
Antonella Mangraviti's innovative work in the field of brain tumor treatment exemplifies the impact of research and development in medicine. Her patents reflect a commitment to improving therapeutic delivery systems, ultimately enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile